| Primary |
| Chronic Obstructive Pulmonary Disease |
36.8% |
| Asthma |
21.8% |
| Bronchitis |
9.2% |
| Bronchospasm |
3.4% |
| Pain |
3.4% |
| Anxiety |
2.3% |
| Atrial Fibrillation |
2.3% |
| Bronchopneumonia |
2.3% |
| Dyspnoea |
2.3% |
| Emphysema |
2.3% |
| Hypothyroidism |
2.3% |
| Pneumonia |
2.3% |
| Arthritis |
1.1% |
| Bipolar Disorder |
1.1% |
| Blood Cholesterol Increased |
1.1% |
| Blood Pressure |
1.1% |
| Blood Pressure Increased |
1.1% |
| Bronchiectasis |
1.1% |
| Diabetes Mellitus |
1.1% |
| Diuretic Therapy |
1.1% |
|
| Dyspnoea |
16.3% |
| Product Substitution Issue |
9.3% |
| Throat Irritation |
9.3% |
| Drug Ineffective |
7.0% |
| Dysgeusia |
7.0% |
| Asthma |
4.7% |
| Chest Pain |
4.7% |
| Drug Effect Decreased |
4.7% |
| Dysphonia |
4.7% |
| Headache |
4.7% |
| Hypoaesthesia |
4.7% |
| Malaise |
4.7% |
| Alopecia |
2.3% |
| Anaphylactic Reaction |
2.3% |
| Apnoea |
2.3% |
| Drug Hypersensitivity |
2.3% |
| Dysphagia |
2.3% |
| Dystonia |
2.3% |
| Epistaxis |
2.3% |
| Haemoptysis |
2.3% |
|
| Secondary |
| Chronic Obstructive Pulmonary Disease |
22.8% |
| Asthma |
12.6% |
| Bronchitis |
11.0% |
| Respiratory Disorder |
8.7% |
| Pyrexia |
7.9% |
| Bronchopneumonia |
4.7% |
| Emphysema |
3.9% |
| Anxiety Disorder |
3.1% |
| Pneumonia |
3.1% |
| Diabetes Mellitus |
2.4% |
| Gastric Disorder |
2.4% |
| Hypothyroidism |
2.4% |
| Osteoporosis |
2.4% |
| Pain |
2.4% |
| Product Used For Unknown Indication |
2.4% |
| Acute Promyelocytic Leukaemia |
1.6% |
| Anxiety |
1.6% |
| Arthralgia |
1.6% |
| Atrial Fibrillation |
1.6% |
| Bronchospasm |
1.6% |
|
| Throat Irritation |
19.5% |
| Dysgeusia |
7.3% |
| Dyspnoea |
7.3% |
| Hypersensitivity |
7.3% |
| Insomnia |
7.3% |
| Chest Pain |
4.9% |
| Drug Effect Decreased |
4.9% |
| Drug Ineffective |
4.9% |
| Hypoaesthesia |
4.9% |
| Tremor |
4.9% |
| Wound Haemorrhage |
4.9% |
| Acute Generalised Exanthematous Pustulosis |
2.4% |
| Asthma |
2.4% |
| Cerebrovascular Accident |
2.4% |
| Depression |
2.4% |
| Drug Withdrawal Syndrome |
2.4% |
| Dysphonia |
2.4% |
| Dystonia |
2.4% |
| Flushing |
2.4% |
| Gait Disturbance |
2.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
42.3% |
| Chronic Obstructive Pulmonary Disease |
9.2% |
| Behcet's Syndrome |
5.5% |
| Hypertension |
5.3% |
| Convulsion |
4.3% |
| Pain |
3.8% |
| Asthma |
3.6% |
| Legionella Infection |
3.0% |
| Depression |
2.6% |
| Emphysema |
2.5% |
| Lower Respiratory Tract Infection |
2.5% |
| Multiple Myeloma |
2.3% |
| Gastrooesophageal Reflux Disease |
2.1% |
| Wheezing |
1.9% |
| Anxiety |
1.7% |
| Idiopathic Thrombocytopenic Purpura |
1.7% |
| Diabetes Mellitus |
1.5% |
| Dyspnoea |
1.5% |
| Osteoporosis |
1.5% |
| Arthritis |
1.3% |
|
| Vomiting |
10.3% |
| Dyspnoea |
8.8% |
| Chronic Obstructive Pulmonary Disease |
7.4% |
| Unresponsive To Stimuli |
7.4% |
| Vision Blurred |
7.4% |
| Mood Altered |
5.9% |
| Renal Failure |
5.9% |
| Weight Decreased |
5.9% |
| Wrist Fracture |
5.9% |
| Death |
4.4% |
| Thrombocytopenia |
4.4% |
| Asthenia |
2.9% |
| Cerebrovascular Accident |
2.9% |
| Decubitus Ulcer |
2.9% |
| Diarrhoea |
2.9% |
| Disease Progression |
2.9% |
| Drug Ineffective |
2.9% |
| Food Poisoning |
2.9% |
| Gastrooesophageal Reflux Disease |
2.9% |
| Pneumonia |
2.9% |
|
| Interacting |
| Dyspnoea |
37.5% |
| Smoking Cessation Therapy |
12.5% |
| Gastric Disorder |
9.4% |
| Asthma |
6.3% |
| Nervous System Disorder |
6.3% |
| Abdominal Discomfort |
3.1% |
| Arthralgia |
3.1% |
| Arthritis |
3.1% |
| Blood Cholesterol Increased |
3.1% |
| Hypertension |
3.1% |
| Thyroid Cancer |
3.1% |
| Thyroid Hormone Replacement Therapy |
3.1% |
| Thyroidectomy |
3.1% |
| Thyroxine Therapy |
3.1% |
|
| Cerebrovascular Accident |
50.0% |
| Abdominal Discomfort |
25.0% |
| Drug Interaction |
25.0% |
|
